Palgan, Angelyn L.
HRN: 13-83-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
CEFUROXIME 1.5GM (VIAL)
09/14/2022
09/20/2022
IV
1.5
Q8
LTCS
Waiting Final Action
Indication: ProphylaxisEmpirical Escalation Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes